
npj Digital Medicine, Год журнала: 2025, Номер 8(1)
Опубликована: Март 18, 2025
We live in interesting regulatory times. In January, a bill was introduced to the US Congress proposing that AI "can qualify as practitioner eligible prescribe drugs" if overseen by States and FDA. This bold contentious move. Even proponents of AI's swift integration into medicine must recognize deep paradox: this proposal emerges even FDA's world-leading infrastructure for oversight faces dismantling.
Язык: Английский